Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Hester Biosciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: HESTERBIO | BSE: 524669

₹2,315.90

up-down-arrow ₹26.10 (1.14%)

As on 28-Aug-2026 10:19IST

Market cap

info icon

₹1,956 Cr

Revenue (TTM)

info icon

₹326 Cr

P/E Ratio

info icon

14.4

P/B Ratio

info icon

4.3

Div. Yield

info icon

0.5 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -22.84 -8.16 4.09 2.41 6.78
EBIT -44.64 -15.56 31.42 21.13 1.42
Net Profit -0.35 -15.38 35.90 21.44 3.26
EPS 506.81 489.84 262.23 68.38 27.01
Book Value -- -- 14.63 8.80 9.55
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 15.8214.9319.9218.9614.22
Net Margin info 12.4711.6538.7016.579.15
Return on equity info 11.0412.1114.6417.059.51
Return on Capital info 12.2911.89--16.219.93
Return on Assets info 6.745.7719.468.644.38
Debt to Equity (x) info ----0.250.520.66

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
16.21
9.93
9.59
9.60
Peer Median
--
19.27
22.77
18.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

14.64

Lower than Peers by 2.36

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
14.64
17.05
9.51
7.41
10.39
Peer Median
17.00
16.19
16.63
14.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

19.46

Higher than Peers by 6.23

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
19.46
8.64
4.38
3.18
4.55
Peer Median
13.24
11.81
12.17
11.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

19.92

Lower than Peers by 4.95

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
19.92
18.96
14.22
11.82
11.16
Peer Median
24.87
23.41
23.35
23.04
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

38.70

Higher than Peers by 19.14

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
38.70
16.57
9.15
6.71
9.96
Peer Median
19.57
17.37
19.25
17.52
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
22.95
14.66
12.58
18.18
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

4.09

Lower than Peers by 8.17

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
4.09
6.91
2.15
14.45
13.23
Peer Median
12.26
16.35
8.42
13.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

31.42

Higher than Peers by 12.13

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
31.42
42.50
22.95
21.15
-31.55
Peer Median
19.29
8.10
14.90
27.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

35.90

Higher than Peers by 8.41

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
35.90
99.42
36.19
-24.50
-29.00
Peer Median
27.49
7.69
15.40
24.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

262.23

Higher than Peers by 238.20

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
262.23
102.41
45.52
-29.06
-32.28
Peer Median
24.03
10.18
21.00
23.62
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
14.63
7.70
4.31
7.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.25

Higher than Peers by 0.25

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
0.25
0.52
0.66
0.82
0.96
Peer Median
0.00
0.05
0.04
0.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
0.07
0.09
0.11
0.21
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.37

Lower than Peers by 1.49

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
1.37
1.37
1.56
2.03
1.53
Peer Median
2.86
2.82
2.59
2.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.89

Lower than Peers by 1.43

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
0.89
0.89
1.00
1.32
0.96
Peer Median
2.32
2.31
2.33
1.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

13.29

Lower than Peers by 36.05

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
13.29
7.94
4.12
2.62
5.31
Peer Median
49.34
45.61
47.50
43.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

29.27

Higher than Peers by 3.96

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
29.27
28.67
23.52
25.82
29.93
Peer Median
25.31
19.84
24.81
26.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.49

Lower than Peers by 0.10

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
0.49
0.50
0.47
0.46
0.44
Peer Median
0.59
0.61
0.74
0.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
92.43
89.02
94.77
91.87
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
78.37
85.58
96.04
109.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
120.46
114.21
106.28
113.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
--
50.33
60.38
84.54
87.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

14.36

Lower than Peers by 23.34

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
14.36
19.31
38.81
62.57
48.58
Peer Median
37.70
37.70
36.17
29.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.30

Lower than Peers by 0.97

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
4.30
2.98
3.39
4.05
4.62
Peer Median
5.27
5.27
5.47
5.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.48

Lower than Peers by 0.28

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
0.48
0.87
0.56
0.43
0.53
Peer Median
0.76
0.76
0.97
0.66
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

22.35

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
22.35
13.04
19.50
21.86
23.52
Peer Median
--
31.54
37.18
37.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,956

Lower than Peers by 1,89,179

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hester Biosciences
1,956
1,074
1,067
1,182
1,293
Peer Median
1,91,135
1,91,135
1,19,795
1,20,138
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...